GlaxoSmithkline Pharmaceuticals divests land in Mumbai

31 Aug 2019 Evaluate

GlaxoSmithkline Pharmaceuticals has divested its lands at Thane in Mumbai admeasuring around 2.40 lakh square meters in favour of Oberoi Realty for a total consideration of Rs 889.50 crore. A small portion, admeasuring around 1,410 square meters, is excluded from this sale owing to a stay order passed by the Bombay High Court on October 12, 2017. The company has paid a sum of Rs 337.46 crore towards obtaining all required statutory and regulatory approvals.

GlaxoSmithKline Pharmaceuticals (GSK Rx India) is one of the oldest pharmaceuticals company. The GSK India product portfolio includes prescription medicines and vaccines.

Glaxosmithkline Phar Share Price

2311.50 -68.35 (-2.87%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×